New drugs in myelofibrosis: Critical assessment of additional value to monotherapy with <scp>JAK</scp> inhibitors

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/https://doi.org/10.1002/ajh.27248

Keywords:

Abstract:

Source: